Illumina, Inc. (0J8Z.L)
0J8Z.L Stock Price Chart
Explore Illumina, Inc. interactive price chart. Choose custom timeframes to analyze 0J8Z.L price movements and trends.
0J8Z.L Company Profile
Discover essential business fundamentals and corporate details for Illumina, Inc. (0J8Z.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
8.97K
Website
https://www.illumina.comCEO
Jacob Thaysen
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
0J8Z.L Financial Timeline
Browse a chronological timeline of Illumina, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 3 Nov 2025
Earnings released on 31 Jul 2025
EPS came in at $1.50 surpassing the estimated $1.01 by +48.51%, while revenue for the quarter reached $1.06B , missing expectations by -0.76%.
Earnings released on 8 May 2025
EPS came in at $0.97 surpassing the estimated $0.94 by +3.19%, while revenue for the quarter reached $1.04B , missing expectations by -2.07%.
Earnings released on 6 Feb 2025
EPS came in at $1.17 surpassing the estimated $0.91 by +28.15%, while revenue for the quarter reached $1.10B , beating expectations by +0.05%.
Earnings released on 5 Nov 2024
EPS came in at $4.41 surpassing the estimated $0.88 by +401.71%, while revenue for the quarter reached $1.08B , beating expectations by 0.00%.
Earnings released on 7 Aug 2024
EPS came in at -$12.50 falling short of the estimated $0.11 by -11.51K%, while revenue for the quarter reached $1.11B , beating expectations by +1.73%.
Dividend declared on 25 Jun 2024
A dividend of $3.11 per share was announced, adjusted to $3.11.
Earnings released on 3 May 2024
EPS came in at -$0.79 falling short of the estimated $0.04 by -2.00K%, while revenue for the quarter reached $1.08B , beating expectations by +2.44%.
Earnings released on 9 Feb 2024
EPS came in at -$1.11 falling short of the estimated $0.02 by -6.22K%, while revenue for the quarter reached $1.12B , beating expectations by +3.19%.
Earnings released on 10 Nov 2023
EPS came in at -$4.77 falling short of the estimated $0.14 by -3.39K%, while revenue for the quarter reached $1.12B , missing expectations by -1.13%.
Earnings released on 10 Aug 2023
EPS came in at -$1.48 falling short of the estimated $0.02 by -9.50K%, while revenue for the quarter reached $1.18B , beating expectations by +1.34%.
Earnings released on 26 Apr 2023
EPS came in at $0.02 surpassing the estimated $0.01 by +252.32%, while revenue for the quarter reached $1.09B , beating expectations by +1.98%.
Earnings released on 8 Feb 2023
EPS came in at -$0.89 falling short of the estimated $0.26 by -444.64%, while revenue for the quarter reached $1.08B , beating expectations by +1.04%.
Earnings released on 2 Oct 2022
EPS came in at -$24.31 falling short of the estimated $0.28 by -8.84K%, while revenue for the quarter reached $1.12B , beating expectations by +0.36%.
Earnings released on 3 Jul 2022
EPS came in at -$3.41 falling short of the estimated $0.61 by -662.32%, while revenue for the quarter reached $1.16B , missing expectations by -4.90%.
Earnings released on 25 Apr 2022
EPS came in at $0.54 falling short of the estimated $0.90 by -39.69%, while revenue for the quarter reached $1.22B , beating expectations by +0.32%.
Earnings released on 9 Feb 2022
EPS came in at $0.71 surpassing the estimated $0.46 by +56.33%, while revenue for the quarter reached $1.20B , beating expectations by +6.36%.
Earnings released on 4 Nov 2021
EPS came in at $1.26 , while revenue for the quarter reached $1.13B .
Earnings released on 3 Oct 2021
EPS came in at $2.07 , while revenue for the quarter reached $1.11B .
Earnings released on 4 Apr 2021
EPS came in at $1.00 , while revenue for the quarter reached $1.09B .
Earnings released on 3 Jan 2021
EPS came in at $1.75 , while revenue for the quarter reached $953.00M .
Earnings released on 27 Sept 2020
EPS came in at $1.21 , while revenue for the quarter reached $794.00M .
0J8Z.L Stock Performance
Access detailed 0J8Z.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.